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ReviewSignaling Pathways in
Mammary Gland Development
synergistic action of insulin, hydrocortisone, and prolac-
tin controls the differentiation of secretory mammary
epithelium (Topper and Freeman, 1980).
Lothar Hennighausen1 and Gertraud W. Robinson
Laboratory of Genetics and Physiology
National Institute of Diabetes and Digestive
and Kidney Diseases The cloning of steroid and peptide hormone receptors
in the 1980s, the identification of downstream signalingNational Institutes of Health
Bethesda, Maryland 20892-0822 components in the 1990s, and the isolation of target
genes provided a basis for the mechanistic understand-
ing of signal transduction pathways. Further, the use of
experimental mouse genetics has been instrumental notUnlike most other organs, development of the mam-
mary gland occurs predominantly after birth, under only in confirming the roles of the candidate genes but
also in the discovery of new signaling pathways in thethe control of steroid and peptide hormones. Once the
gland is established, cycles of proliferation, functional mammary gland. Among the genes identified to control
mammary development were some of the “usual sus-differentiation, and death of alveolar epithelium occur
repeatedly with each pregnancy. Although it is unique pects” but also genes that had not been linked pre-
viously to mammary gland development. Finally, thein this respect, the signaling pathways utilized by the
gland are shared with other cell types, and have been combination of experimental mouse genetics with ex-
perimental tissue recombination has provided evidencetailored to meet the needs of this secretory tissue.
Here we discuss the signaling pathways that have for cell-autonomous signaling pathways and signaling
cascades that depend on crosstalk between epithelialbeen adopted by the mammary gland for its own pur-
poses, and the functions they perform. and stromal cells in the developing organ (e.g., Robinson
et al., 2000).
Development and Structure
A Historical Perspective Development of the mammary gland occurs in defined
During the past 100 years, extensive efforts have been stages that are connected to sexual development and
made to investigate the regulation of mammopoiesis reproduction. These are embryonic, prepubertal, puber-
and to understand the endocrine signals and pathways tal, pregnancy, lactation, and involution. Two cellular
that control mammary epithelial cell proliferation and compartments contribute to the gland, the epithelium
differentiation. Advances in the first three decades of and the surrounding stroma, which are derived embryo-
the 20th century were based on the development of logically from ectoderm and mesoderm, respectively.
techniques for multiple endocrinectomies and the isola- The epithelium consists of a branched ductal system
tion of bioactive hormones. Evidence for ovarian control that develops mainly during puberty (Figure 1d) and a
of mammary development first emerged 100 years ago, lobuloalveolar compartment that develops during preg-
when Halban (1900) demonstrated that oophorectomy nancy (Figure 1e). The ducts branch into decreasingly
(ovary removal) caused mammary regression and that smaller ductules, which terminate in lobules. Lobules are
transplanted ovaries prevented this atrophy. The re- composed of alveoli, which in turn consist of secretory
sponsible bioactive compounds turned out to be pro- epithelial cells that undergo functional differentiation
gesterone and estrogen (Allen et al., 1924). When hy- with parturition. The ducts are surrounded by a continu-
pophysectomy (removal of the pituitary gland) was a ous layer of contractile myoepithelial cells and the alve-
routine experimental procedure in the 1920s, it became oli have a more open network of myoepithelium. These
clear that factors other than ovarian hormones were cells contract in response to oxytocin stimulation, which
required for mammopoiesis. The era of peptide hor- results in milk release.
mones in mammary development was born in 1928 when
Stricker and Grueter in Strasbourg induced milk secre- Epithelial-Mesenchymal Signaling
tion artificially in castrated virgin rabbits with pituitary during Embryonic Development
extracts from lactating animals (Stricker and Grueter, The initial stages of mammary development are inde-
1928). Five years later, Riddle and his colleagues from pendent of systemic cues and instead depend on recip-
the Carnegie Institution of New York (now the Cold rocal signaling between the epithelium and the mesen-
Spring Harbor Laboratory) purified the respective pitu- chyme. In the mouse embryo, five pairs of ectodermal
itary hormone (Riddle et al., 1933) and named it prolactin placodes appear between embryonic days 10 and 11.
(Prl). As early as 1906 it became evident that the placenta They form as distinct spots in two lines running ventrally
also secretes mammotrophic substances (Lane-Clay- just inside the limbs from the neck to the genital area.
pon and Starling, 1906), which include placental lacto- The placodes form buds, which slowly increase in size
gens, estrogens, progesterone, and gonadotrophins. up to embryonic day 15 (Figure 1a). During this period,
The introduction of mammary organ cultures that could the epithelial bud is surrounded by a halo of layered
be maintained in vitro in chemically defined media sup- mesenchymal cells, the primary mammary mesen-
plemented with a cocktail of hormones revealed that chyme. Cell proliferation intensifies at the tip of the bud
and leads to the formation of a primary sprout, which
grows out of the surrounding mesenchyme toward the1Correspondence: hennighausen@nih.gov
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Figure 1. Fetal and Adult Stages of Mam-
mary Gland Development
Development of the mammary gland begins
in the fetus. The anlagen (arrows) are visual-
ized by whole-mount in situ hybridization with
PTHrP (a). A small ductal tree is present in
newborn animal (b); the arrow points to the
nipple region. The size and branching pattern
of the ductal system increases only moder-
ately until the onset of puberty at 3 weeks (c);
the arrow points to a terminal end bud (TEB).
Accelerated growth and branching induced
by puberty hormones leads to the formation
of an extended ductal system that fills the
entire fat pad in a mature virgin mouse (d).
Alveolar development occurs during preg-
nancy (e). The alveolar epithelial compart-
ment is eliminated during involution (f). All
images are taken at the same magnification
to show the extent of epithelial development.
prospective mammary fat pad. This fat pad forms the in which both Msx1 and Msx2 have been inactivated
lack mammary buds (Satokata et al., 2000). By contrast,stroma of the adult mammary gland. Continued prolifer-
ation and branching leads to the formation of a small Msx1 alone is required for tooth development beyond
the late bud stage. This suggests cell- and organ-spe-ductal tree at birth (Figure 1b). Mesenchyme from the
prospective mammary region is able to induce mam- cific differences in the expression levels and patterns
of these transcription factors and/or differences in themary epithelial differentiation when combined with dor-
sal epidermis (Cunha et al., 1995), demonstrating that a signaling pathways elicited in the recipient mesen-
chyme. Tissue recombination experiments in tooth budsmesenchymal signal first determines epithelial develop-
ment. As in teeth and hair, reciprocal interactions be- and whiskers have shown that the requirement for these
transcription factors is temporally restricted and theirtween the two tissues are critical for further develop-
ment of the gland. Once the early bud is initiated, it action is non-cell-autonomous (Kratochwil et al., 1996).
Transient expression is required in one tissue to induceinduces the formation of a characteristic primary mam-
mary mesenchyme in adjacent mesenchymal cells (Fig- changes in the other tissue to promote development
of the organ. The development of Msx1-deficient toothure 2). The “primary mammary mesenchymal cells” are
morphologically distinct from the more distant dermal buds is arrested at the late bud stage but can be rescued
by treatment with BMP4 (Bei et al., 2000), suggestingmesenchyme and express receptors for estrogen and
androgen, the transcription factors Lef-1, Msx1, and that this is the epithelial signal that causes differentiation
of the dental papilla mesenchyme. No specific down-Msx2, the growth factors BMP4 and FGF7, and the ex-
tracellular matrix molecules tenascin C and syndecan-1 stream signals activated by Msx1 and 2 have been iden-
tified in the mammary gland. It will be interesting to see(for review see Robinson et al., 1999). Tissue recombina-
tion experiments have demonstrated that the capacity of whether they are identical in teeth, hair, and mammary
glands or whether different responses ensue in a tissue-the mammary epithelium to induce these mesenchymal
markers is transient and is lost at later stages (Heuberger specific context reflecting the differences in morphology
and differentiation of the organs.et al., 1982).
Lef-1, Msx1, and Msx2 expression is not unique to Epithelial-mesenchymal signaling through PTHrP
(parathyroid hormone related peptide) and its receptorthe early mammary anlage and is also found in teeth,
hair, and whiskers. Therefore, it does not come as a provides important cues for the elongation of the pri-
mary sprout (Figure 2). PTHrP is expressed in mammarysurprise that the inactivation of the genes encoding
these transcription factors leads to arrest of the devel- epithelium, and the signal is received by the surrounding
mesenchymal cells, which express the receptor. Inter-opment of all these ectodermal appendages, including
the mammary gland, at the bud stage (Figure 3; Table ruption of PTHrP signaling causes developmental arrest
of the mammary gland primordium before elongation of1). In the mammary gland, Lef-1 RNA is first found at
sites where the placodes are formed (van Genderen the bud into a primary sprout begins. Identical pheno-
types were observed in mice lacking the ligand PTHrPet al., 1994), followed by a shift to the mesenchyme
(Satokata et al., 2000). The genes encoding Msx1 and or the PTH/PTHrP receptor PPR1. The arrest occurs 4
days after PTHrP expression begins in the epithelialMsx2 initially are coexpressed in the developing plac-
odes (Phippard et al., 1996). At a slightly later stage, mammary bud (Wysolmerski et al., 1998). In the absence
of the signal, markers for the primary mammary mesen-Msx1 gene expression is downregulated, whereas Msx2
gene expression occurs also in the mesenchyme (Sato- chyme are not expressed. Most noticeable is an ab-
sence of the androgen receptor and tenascin C expres-kata et al., 2000). Mammary gland development is not
affected by the absence of Msx1 alone. However, mice sion, whose expression can be restored by expression
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Figure 2. Stromal and Epithelial Signals Op-
erative in the Fetal Anlage
Genetic and tissue transplant experiments
have implicated the genes listed. The primary
mammary mesenchyme (MM), which sur-
rounds the mammary epithelial bud (ME), is
distinct from the dermal mesenchyme (DM)
(light gray). E, epidermis.
of a PTHrP transgene in the knockout mice (Dunbar et synthesis to maintain pregnancies and execute mam-
mary ductal development. Wild-type pituitary isograftsal., 1999). Similarly, ectopic expression of PTHrP in the
epidermis causes the adjacent dermal cells to assume were able to partially rescue the defects observed in
ER null mice, further emphasizing that mammary devel-characteristics of primary mammary mesenchyme and
differentiate as nipple cells (Foley et al., 2001). Thus, opment is controlled to a large extent by systemic cues.
The physiological effects of progesterone are medi-PTHrP is the first signaling molecule known to be pro-
duced by the embryonic mammary epithelial cells that ated by the interaction of two receptors (PR-A and PR-B)
that are encoded by a single gene containing two dis-influence cell fate decisions in the surrounding mesen-
chyme. These in turn evoke a proliferation and differenti- tinct promoters. The PR-B isoform is identical to PR-A
but contains additional 165 amino-terminal amino acidsation response in the epithelium. Lack of PTHrP signal-
ing also affects bone development by regulating as the result of a new translational start site. Mice lacking
both PR isoforms display pleiotropic reproductive ab-chondrocyte proliferation and differentiation and mice
missing PTHrP or the PPR1 receptor show accelerated normalities, including an inability to ovulate and severely
limited mammary gland development (Lydon et al.,differentiation of chondrocytes (Chung et al., 1998).
PTHrP also functions in the adult epidermis, and knock- 1995). Since ovarian dysfunction and a lack of signaling
through the hypothalamic/pituitary axis significantly af-out mice display premature differentiation of keratino-
cytes, hypoplastic sebacious glands, and a fibrotic der- fect mammary development, mammary epithelial trans-
plants were used to establish the direct function of PRmis (Foley et al., 1998).
in epithelial cells (Brisken et al., 1998). In the absence
of the PR, alveolar development during pregnancy isSteroid Hormones Control Ductal
and Alveolar Development completely absent. However, it is not known whether
the PR and PrlR pathways act independently or areFollowing the embryonic and prepubertal stages, further
development of the mammary gland becomes hormone- interdigitated. Since the PR-A and PR-B isoforms pos-
ses different transcriptional activities in vitro, unique independent and continues at the onset of puberty. The
systemic steroid hormones that regulate this process vivo functions were predicted. Specific mutation of the
initiating ATG used in the PR-A form using Cre/loxP-were initially revealed by hormone depletion, through
endocrine ablations and defined hormone reconstitution based site-specific recombination resulted in mice that
expressed the PR-B isoform only (Mulac-Jericevic etstudies (for review see Imagawa et al., 1994). Gene-
targeting approaches have identified specific and over- al., 2000). Like the PR null mice, PR-A null mice were
infertile, partly due to defective uterine implantation. Inlapping roles of the progesterone and estrogen recep-
tors, plus other coactivators and transcription factors these mice, ductal branching and alveolar budding was
observed upon stimulation with estrogen and progester-that mediate signaling processes in the developing
mammary gland (Figure 3; Table 1). The primary mecha- one. Based on this assay, it appears that the PR-B iso-
form is sufficient for ductal outgrowth, branching, andnism of steroid hormone function is through binding to
specific nuclear receptors, which activate defined genes the formation of alveolar lobules. However, a bona fide
proof of the role of either isoform will require mammaryin a ligand-dependent manner. ER and PR are found at
high levels in ovaries, uterus, mammary, and pituitary gland transplants or a cell-specific deletion of the indi-
vidual isoforms. Although the pathways activated byglands. ER null mice are infertile, and ductal develop-
ment during puberty is severely curtailed. Impaired duc- progesterone are poorly understood, it is now clear that
they encompass the control of cell proliferation throughtal development is not only the result of a lack of ER in
the mammary epithelium and stroma, but also due to the activating the wnt pathway in a paracrine fashion
(Brisken et al., 2000). Estrogen and progesterone arefailure of estrogen signaling through the hypothalamic/
pituitary axis (Bocchinfuso et al., 2000). ER null mice primarily known for their role in the development and
function of the female reproductive system. Since thehave reduced levels of prolactin, which results in a non-
functional corpus luteum and insufficient progesterone need for a functional mammary gland was dependent
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Figure 3. Hormones and Genes that Control Development of the Mammary Gland
The schematic drawing represents different developmental stages. The anlage is composed of epithelium (dark knob) and stroma (gray
surrounding). The oval shown in the postnatal stages depicts the mammary fat pad (stroma). The solid green circle represents the nipple (N)
from which the ducts originate. The ends of growing ducts form terminal end buds (TEB) during puberty. Mammary ducts (D) are shown as
solid lines and the lobuloalveolar structures are presented as yellow circles (A). The hormones that control distinct developmental windows
are shown below the arrows. The genes that have been implicated genetically in developmental processes are listed above the respective
stages. Epidermal growth factor (EGF) signals through the stroma and controls early ductal outgrowth. Together with estrogen, it also controls
ductal elongation and branching during puberty. Progesterone, placental lactogens, prolactin, and the osteoclast differentiation factor signal
alveolar proliferation and differentiation during pregnancy and possibly lactation. The signals inducing tissue remodeling during involution
have not been defined. The genes that control distinct stages of mammary development are shown. Ductal elongation and branching during
puberty is controlled by inhibinB, CSF-1, the progesterone receptor, and wnt. Proliferation and differentiation of mammary alveolar cells is
controlled by the prolactin receptor, Stat5, RANKL, cyclinD1, p27, Id2, and C/EBP. Mammary function during lactation is controlled by
prolactin through Stat5, and tissue remodeling and cell death during involution by Stat3, bax, and bcl-x.
on a successful pregnancy, it appears more than pru- puberty was retarded in SRC-3 null mice (Xu et al., 2000).
However, this was not the result of an intrinsic defectdent for the evolutionary process to use the same set
of hormones for both developmental processes. in the mammary epithelium but instead was a secondary
effect. SRC-3 null mice have decreased levels of sys-Nuclear receptors require coactivators to mediate
transcriptional activation of their target genes. The fam- temic estrogen, which result in delayed sexual matura-
tion and thus may account for the majority of the ductalily of steroid receptor coactivators (SRC) consists of three
members, SRC-1, GRIP1 (SRC-2), and p/CIP (SRC-3), outgrowth defect. They also show decreased ovulation,
lower pregnancy frequency, and small litter sizes, sug-which affect transcriptional activation through several
mechanisms. These include direct interactions with li- gesting a general role of SRC-3 in female reproduction.
Administration of pharmacological doses of estrogengand bound nuclear receptors and generic transcription
factors, interactions with common transcriptional co- and progesterone could induce ductal side branching in
control mice, but SRC-3 null epithelium did not undergoactivators (CBP, p300), and participation in chromatin
remodeling through their intrinsic histone acetyltransfer- branching to the same degree, suggesting some effects
intrinsic to the mammary epithelium as well (Xu et al.,ase activity. SRC-3 is highly amplified in 10% of primary
breast cancers and its mRNA is overexpressed in the 2000). For a better understanding of the role of SRC-3,
it will be necessary to investigate ductal and alveolarmajority of primary breast cancers (Bautista et al., 1998),
suggesting a role for SRCs in mammary development development during pregnancy in transplanted tissue.
Deletion of SRC-1 resulted in an even milder phenotypeand breast cancer. Although in vitro assays seemed to
indicate redundancy among SRCs, there is biological (Xu et al., 1998). Females were fertile but showed a
partial resistance to estrogen and progesterone. As inspecificity in vivo. Outgrowth of mammary ducts during
Review
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Table 1. Genetic Pathways Controlling Mammary Development and Other Organs
Signaling Pathways Mammary Defects Reproductive System
Steroid Hormones
Estrogen receptor  Absence of ductal outgrowth Infertile
Progesterone receptor Impaired alveolar development Infertile
SRC-1, SRC-3 Reduced ductal branching Fertile
Peptide Hormone Pathways
Prolactin Reduced ductal branching Infertile
Prolactin receptor Reduced ductal branching, impaired Nonfunctional corpus luteum
alveolar development
Stat3 Delayed involution ND
Stat5a Impaired differentiation None
Stat5b None Nonfunctional corpus luteum
Stat5a/b ND Nonfunctional corpus luteum
Bcl-x ND Loss of primordial germ cells
RANKL or RANK Impaired alveolar development ND
PTHrP or PPR1 Lack of embryonic mesenchyme and prim. ND
sprout growth
Cell Cycle
Cyclin D1 Impaired alveolar development ND
p27 Impaired alveolar development Infertile, nonfunctional corpus luteum
p27 and cyclin D1 Normal development Same as p27
Id2 Impaired alveolar development ND
Transcription Factors
C/EBP Impaired ductal and alveolar development Lack of corpus luteum
LEF-1 Arrest at embryonic bud stage ND
Msx1 and Msx2 Arrest at embryonic bud stage ND
Signaling molecules that control proliferation, survival, differentiation, and death of mammary epithelial cells as determined through experimental
genetics of the mouse. The genes that have been deleted using conventional and cell-specific recombination approaches are shown in the
left column. The effects on mammary glands and the reproductive system are listed in the right columns. ND, not described.
SRC-3 null mice, mammary development was slightly (Ormandy et al., 1997) and the downstream Jak2-Stat5
reduced in the absence of SRC-1, and most of this effect pathway (Liu et al., 1997). Binding of prolactin or placen-
can be attributed to insufficient steroid signaling through tal lactogens to the PrlR induces receptor dimerization
the ovary. Thus, although individual steroid receptor and the phosphorylation of specific tyrosine residues
coactivators can significantly modulate the transcrip- by receptor-associated Jak2. Subsequently, the tran-
tional activity of steroid hormone receptors in vitro, their scription factors Stat5a and 5b (the two proteins are
individual roles appear to be more restricted in vivo. The 92% identical) are recruited through their SH2 domains
presence of several coactivators and some degree of and phosphorylated by Jak2. Phosphorylated Stat5a
functional redundancy may obscure the full potential of and Stat5b form homo- and hetereodimers and translo-
each molecule in vivo. cate to the nucleus where they activate genetic pro-
The importance of hormone receptors in cell prolifera- grams of cell proliferation and differentiation. Deletion
tion is further emphasized by results obtained in an ap- of the two Stat5 genes, individually or together, provided
parently unrelated knockout model. Inactivation of the mechanistic insight into this signaling pathway in differ-
transcription factor C/EBP results in reduced ductal ent cell types, including mammary epithelium and hema-
growth and morphogenesis and abrogation of alveloar topoietic cells. In addition, these experiments suggest
differentiation in an epithelial cell autonomous way that Stat5 function is dosage dependent. Stat5a null
(Robinson et al., 1998; Seagroves et al., 1998). In C/EBP mice fail to develop functional mammary tissue during
null mammary glands, a much higher number and al- pregnancy as a result of reduced epithelium and im-
tered distribution of PR-positive cells was found (Sea- paired differentiation (Liu et al., 1997). After multiple
groves et al., 2000). These data suggest that C/EBP is pregnancies, some functional mammary development
involved in the cell fate decision leading to PR expres- can be obtained in Stat5a null mice, which coincides
sion which then affects cell proliferation through a para- with increased Stat5b levels (Liu et al., 1998), suggesting
crine mechanism. that Stat5b can partially compensate for the absence
of Stat5a. Since Stat5a/b null mice have a nonfunctional
corpus luteum and are infertile (Teglund et al., 1998),Jak2-Stat5 Signaling Controls Cell Specification,
it was not possible to directly assess the combinedProliferation, and Differentiation
contribution of both Stat5a and 5b (referred to as Stat5)The Jak-Stat signaling pathway exists in most multicel-
to the development of mammary tissue during thelular organisms and has been adapted during evolution
course of a normal pregnancy. However, this was ac-to accommodate many diverse cytokine signals (Leo-
complished through the transplantation of Stat5 nullnard and O’Shea, 1998; Ihle 2001). Proliferation and dif-
mammary epithelium into wild-type mice. Stat5 nullferentiation of secretory mammary epithelium is depen-
dent on the presence of the prolactin receptor (PrlR) mammary epithelia developed ducts but failed to form
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alveoli during pregnancy (Miyoshi et al., 2001), sug- that the prolactin and RANKL pathways are intimately
gesting that the Stat5 pathway is critical for the determi- linked comes from studies of PrlR null mice that exhibit
nation, proliferation, and differentiation of mammary al- defects in skull bone formation (Clement-Lacroix et al.,
veoli during pregnancy. 1999). The defect is linked to the PrlR in osteoblasts,
Stat5 controls different developmental processes, but the same cells that secrete RANKL.
its target genes remain ill defined. A potential target in
hematopoietic cells (Socolovsky et al. 1999; Kieslinger The Cell Cycle
et al., 2000) is the bcl-x gene, which encodes a cell Cyclins activate and provide substrate specificity for
survival protein. Deletion of the bcl-x gene results in cyclin-dependent kinases (Cdks). Three D-type cyclins
impaired erythropoiesis, reminiscent to what has been (D1–D3) are expressed in the G1 phase of the cell cycle,
seen in Stat5 null mice (Socolovsky et al., 1999). How- and their expression is largely controlled by extracellular
ever, transcription of the bcl-x gene in mammary epithe- signals, in particular mitogens. Mice in which the
lium is not under Stat5 control, and unlike Stat5, Bcl-x cyclinD1 gene has been deleted display several defects,
is not required for normal mammary development and including neurological abnormalities, retinal hyperpla-
function (Walton et al., 2001). sias, and a failure of mammary tissue to fully develop
during pregnancy (Sicinski et al., 1995; Fantl et al., 1995).
Local Control of Cell Proliferation through the As substantial alveolar proliferation and differentiation
Osteoclast Differentiation Factor RANKL remains in the absence of cyclinD1, it is likely that
Mammary development is not only controlled by sys- cyclinsD2 and D3 also contribute to the development
temic hormones, but also by peptides produced either of the alveolar compartment. In addition to providing
in the stromal or epithelial compartment. These include insight into the function of cyclins in normal mammary
the osteoclast differentiation factor RANKL (Fata et al., development, these investigations have suggested that
2000), inhibinB (Robinson and Hennighausen, 1997), cyclinD1 could be a useful target for blocking progres-
and members of the hedgehog (Lewis et al., 1999) and sion of some mammary tumors. Transgenic mice ex-
TGF families (Nguyen and Pollard, 2000). The TNF fam- pressing the neu and ras oncogenes under control of
ily member RANKL (also called osteoprotegerin) was the MMTV-LTR succumbed to mammary tumors within
originally identified as a key osteoclast differentiation a few months in the presence of cyclinD1 but stayed
factor essential for bone remodeling (Kong et al., 1999). virtually tumor free in the absence of cyclinD1 (Yu et al.,
RANKL binds to its receptor RANK (receptor activated 2001). By contrast, tumors induced by c-myc and wnt1
by NF-B), which is an intrinsic cell surface determinant progressed in the absence of cyclinD1. This suggests
that mediates effects on bone resorption. Like PTHrP, that cyclinD1 regulates specific growth pathways and
RANKL and its receptor RANK control the development that an anti-cyclinD1 therapy might be used to treat
of both bone and mammary cells. In the absence of certain breast cancers.
RANKL or its receptor RANK, pregnancy-induced alveo- Cyclin-dependent kinase inhibitors negatively regu-
lar development is reduced (Fata et al., 2000). Although late Cdks and serve as checkpoint controls for cell cycle
initial alveolar budding occurs during early pregnancy, progression (Sherr and Roberts, 1999). The Cip/Kip fam-
expansion and differentiation of the alveoli is arrested.
ily of proteins includes p21, p27, and p57, which inhibit
Transplantation of epithelium devoid of the ligand or the
all cyclin-Cdk complexes. p27 binds all cyclinD-Cdk4
receptor into control stroma demonstrated epithelial cell
complexes and reversibly arrests in the G1 phase ofautonomy. Interestingly, while the receptor is expressed
the cell cycle, suggesting that it controls the G1 to Sthroughout development, the ligand is present only after
transition. Genetic evidence comes from the deletion ofday 12.5 of pregnancy, the time when the developmental
the p27 gene from the mouse genome, which results indefects become apparent. The developmental lesions
larger mice with hyperplasias in many organs (Fero etin RANK and RANKL null mammary epithelium are histo-
al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996).logically similar to those observed in both PrlR null and
Based on these observations, it might have been ex-Stat5 null mice, suggesting that the two pathways either
pected that loss of p27 would have resulted in hyperpro-operate in parallel or are dependent upon each other.
liferation of mammary epithelium. It was therefore sur-Expression of RANKL can be induced by progesterone,
prising that p27 null mammary epithelium does notPTHrP, and prolactin, suggesting that it is a downstream
develop normally during pregnancy (Muraoka et al.,mediator of one of these hormones. As activation of
2001). Instead, during pregnancy p27 null mammary epi-Stat5 precedes RANKL expression by approximately 1
thelium displays a decreased proliferation rate and de-day, it is possible that placental lactogens and prolactin
layed differentiation, reminiscent of the situation inare the key inducers. Furthermore, Stat5a activity in
cyclinD1 null mice. The combined loss of cyclinD1 andmammary epithelium was preserved in RANKL null mice,
p27 results in overtly normal mammary developmentwhich excludes RANK signaling as an activator of Stat5.
(Geng et al., 2001). This restoration of normal mammarySeveral lines of evidence from gene deletion mice
development upon deletion of both genes suggests thatsuggest that prolactin and RANKL induce identical or
cyclin D1 and p27 function antagonistically in mammaryrelated developmental programs during pregnancy.
epithelium. However, since both p27 and cyclinD1 nullFirst, the histological and molecular consequences of
mammary epithelium both exhibit impaired mammaryinactivation of the PrlR and RANK pathway are similar.
development, one has to assume that a second, yet toSecond, cell proliferation is impaired in the absence
be defined, pathway is activated in the absence of bothof each pathway. Third, inactivation of both pathways
proteins.results in increased apoptosis (Humphreys and Hen-
nighausen, 1999; Fata et al., 2000). Additional evidence Transcription factors from the basic helix-loop-helix
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(HLH) family are critical for cell proliferation and differen- et al., 1999) with inducible gene switches, such as the
tetracycline system (Furth et al., 1994; Ewald et al., 1996;tiation during developmental processes. Id proteins are
negative modulators for these transcription factors. D’Cruz et al., 2001). The physiological and develop-
mental changes observed by conventional gene deletionThey lack the basic DNA binding domain but retain the
HLH dimerization motif and thus function in a dominant- in mice not only reflect the loss of particular pathways,
but also the activity of compensatory pathways andnegative fashion. Id2 is essential for the cell population
that establishes peripheral lymph organs and mammary other secondary physiological changes. The true role of
any specific protein at any given time point in develop-development (Mori et al., 2000). Id2 null mammary epi-
thelium exhibits reduced proliferation during early stages ment can only be established if it becomes possible to
delete the respective gene not only in defined cell typesof pregnancy, and a lack of functional differentiation
and increased rates of apoptosis in late pregnancy. As but also during predetermined time windows. Only then
will we know whether a specific pathway controls cellId2 first appears in mammary epithelial cells at the time
when Stat5 is activated, it is possible that Id2 is a target specification, proliferation, differentiation, maintenance
of function, or survival.gene in the prolactin pathway. The impaired cell prolifer-
ation in early pregnancy in Id2 null mammary epithelium
coincides with increased expression of p21 and p27 Conclusions
(Mori et al., 2000), suggesting that Id2 is also required The introduction of mammary glands is a recent event
for cell cycle progression in mammary epithelial cells. in evolution, occurring with the appearance of mammals
Id2 is also a dominant-negative antagonist of the retino- about 200 million years ago. Many, if not all, of the
blastoma (Rb) family. Rb null embryos die in utero be- genetic pathways that control the development of mam-
cause of widespread proliferation and defects in neuro- mary tissue are used in organ systems that appeared
genesis and hematopoiesis. Id2-Rb double knockout earlier in evolution. Thus, the development of mammary
embryos survive (Lasorella et al., 2000) supporting the glands relied on the recruitment of regulators from other
concept Id2 is a negative growth regulator. Although sources, such as epidermal appendages, bone morpho-
Rb is not required for mammary development per se genesis, reproduction, and hematopoiesis, and their
(Robinson et al., 2001), these findings could indicate subversion into signaling components for a new and
an integral role for Id2 in the reciprocal regulation of unrelated cell type. It is intriguing to speculate that the
differentiation and proliferation of specific cell types. salvage and recycling of signaling switches from cell
systems that are constantly renewed or remodeled
Challenges Ahead might have facilitated the establishment of this new
Experimental mouse genetics and tissue transplantation organ.
approaches have provided mechanistic insight into
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